Clinical Trial Update: Safety and Effectiveness of the PXL-Platinum 330 System [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for the PXL-Platinum 330 System across Phase 1 and Phase 2 assessing safety and effectiveness for corneal conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus
• Pellucid Marginal Corneal Degeneration

Drugs mentioned

• PXL Platinum 330 System

Snippet

Sponsor: Colorado Eye Consultants/Cornea Consultants of Colorado | Conditions: Corneal Ectasia, Keratoconus | Phase 1, Phase 2 | Status: UNKNOWN